4Johnson MD, Drew RH, Perfect JR. Chest discomfort associated with liposomal amphotericin B : report of three care and review of the literature [J].Pharmacotherapy, 1998,18 ( 5 ) : 1053-1061.
5Roden MM, Nelson LD, Knudsen TA, et al. Trial of acute infusion- related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics[J]. Clin Infect Dis, 2003,36 (10) : 1213-1220.
6Stuecklin-Utsch A, Hasan C, Bode U, et al. Pancreatic toxicity after liposomal amphotericin B [J]. Mycoses, 2002,45 ( 5-6 ) : 170-173.
二级参考文献3
1Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species[J]. Clin Infect Dis,1995, 20(6): 1526-1530.
2Sharkey PK, Graybill JR, Johnson ES et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS[J]. Clin Infect Dis,1996, 22(2): 315-321.
3Cagnoni PJ. Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients[J]. J Antimicrob Chemother, 2002, 49(Suppl S1): 81-86.
5Fujita Y, Kasahara K, Konishi M, et al. Amphotericin B-induced nephro- genic diabetes insipidus in a case of cryptoeoecemia [ J ]. Intern Med,2005,44(5):458.
6Gerbaud E, Tamion F, Girauh C,et al. Persistent acute tubular toxicity after switch from conventional amphotericin B to liposomal amphotericin B (Ambisome) [J] .J Antimicrob Chemother, 2003,51 (2) :473.
9Karimzadeh I, Farsaei S, Khalili H, et al. Are salt loading and prolonging infusion period effective in prevention of amphoteriein B-induced nephro- toxicity [J]. Expert Opin Drug Saf, 2012,11 ( 6 ) : 969.
10Bekersky I, Fielding RM, Dressier DE,et al. Pharmaeokinetics, excre- tion, and mass balance of liposomal amphoteriein B (AmBisome) and amphotericin B deoxycholate in humans [J]. Antimicrob Agents Chemoth- er,2002,46(3) :828.
